Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United States

Gary S Marshall,Parinaz K Ghaswalla,Lindsay G S Bengtson,Ami R Buikema,Tim Bancroft,Eleena Koep,Patricia Novy,Cosmina S Hogea

CLINICAL INFECTIOUS DISEASES（2022）

引用 3|浏览9

暂无评分

摘要

Meningococcal vaccination is recommended for patients with complement component deficiencies (CDs) in the United States. In this retrospective database study, only 4.6% and 2.2% of patients received MenACWY and MenB vaccination, respectively, within 3 years of CD diagnosis. Thus, meningococcal vaccination rates among patients with CDs need to be improved.

查看译文

关键词

meningococcal vaccine, complement component deficiencies, meningococcal serogroups A, C, W, and Y (MenACWY), meningococcal serogroup B (MenB)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要